Spectrum Pharma (NASDAQ: SPPI) announced publication of results from the pivotal clinical study for EVOMELA, used for myeloablative conditioning in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE